Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
19 February 2015 |
Main ID: |
NCT00032734 |
Date of registration:
|
29/03/2002 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
|
Scientific title:
|
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Escalation, Multicenter Study Evaluating the Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion. |
Date of first enrolment:
|
June 2001 |
Target sample size:
|
35 |
Recruitment status: |
Completed |
URL:
|
http://clinicaltrials.gov/show/NCT00032734 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
|
Phase:
|
Phase 2
|
|
Countries of recruitment
|
Belgium
|
Canada
|
France
|
Germany
|
Hungary
|
United States
| | |
Contacts
|
Name:
|
ICD CSD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Sanofi |
| | |
Key inclusion & exclusion criteria
|
SIADH of any origin
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Hyponatremia
|
Syndrome of Inappropriate ADH (SIADH) Secretion
|
Intervention(s)
|
Drug: satavaptan (SR121463B)
|
Primary Outcome(s)
|
serum sodium concentration
|
Secondary Outcome(s)
|
safety assessment
|
Secondary ID(s)
|
LTS10208
|
SR121463
|
LTS5066
|
DFI4488
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|